Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS‐induced model of colitis in mice
- 12 July 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 112 (11) , 3322-3333
Abstract
Causal connections between dipeptidyl peptidase IV, also known as CD26 molecule (DPP IV/CD26) and inflammatory bowel disease (IBD) have been shown, but mechanisms of these interactions are unclear. Our hypothesis was that DPP IV/CD26 could affect the neuroimmune response during inflammatory events. Therefore, we aimed to evaluate its possible role and the relevance of the gut–brain axis in a model of IBD in mice. Trinitrobenzenesulfonic acid‐induced (TNBS) colitis was induced in CD26‐deficient (CD26−/−) and wild‐type (C57BL/6) mice. Pathohistological and histomorphometrical measurements were done. Concentrations and protein expressions of DPP IV/CD26 substrates neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) were determined. Concentrations of IL‐6 and IL‐10 were evaluated. Investigations were conducted at systemic and local levels. Acute inflammation induced increased serum NPY concentrations in both mice strains, more enhanced in CD26−/−mice. Increased NPY concentrations were found in colon and brain of C57BL/6 mice, while in CD26−/−animals only in colon. VIP and IL‐6 serum and tissue concentrations were increased in both mice strains in acute inflammation, more pronouncedly in CD26−/−mice. IL‐10 concentrations, after a decrease in serum of both mice strains, increased promptly in CD26−/−mice. Decreased IL‐10 concentration was found in brain of C57BL/6 mice, while it was increased in colon of CD26−/−mice in acute inflammation. DPP IV/CD26 deficiency affects the neuroimmune response at systemic and local levels during colitis development and resolution in mice. Inflammatory changes in the colon reflected on investigated parameters in the brain, suggesting an important role of the gut–brain axis in IBD pathogenesis. J. Cell. Biochem. 112: 3322–3333, 2011.Keywords
This publication has 49 references indexed in Scilit:
- Animal models of IBD: linkage to human diseaseCurrent Opinion in Pharmacology, 2010
- Inflammation in the Intestinal Tract: Pathogenesis and TreatmentDigestive Diseases, 2009
- DPP‐IV inhibition enhances the antilipolytic action of NPY in human adipose tissueDiabetes, Obesity and Metabolism, 2009
- The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and agePeptides, 2008
- Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental ColitisPLOS ONE, 2008
- Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic HypertensionHypertension, 2008
- Interleukin-6 Genetic Ablation Protects from Trinitrobenzene Sulfonic Acid-Induced Colitis in MiceNeuroimmunomodulation, 2006
- IL-10 gene therapy prevents TNBS-induced colitisGene Therapy, 2002
- Dipeptidyl Peptidase IV (DP IV, CD26) in Patients with Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976